ResearcherThe University of TokyoNo recent work listed

Chiharu Moriya

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0723-4040; OpenAlex author ID A5061470532. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper

Papers 2

PRDM14 is overexpressed in chronic pancreatitis prior to pancreatic cancer. Co-author DOI 10.1002/2211-5463.12519 ↗
Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice. Co-author DOI 10.1093/carcin/bgx040 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kohzoh Imai · 2 shared papers, 2017–2018 · strength 0.22
- Paper PRDM14 is overexpressed in chronic pancreatitis prior to pancreatic cancer. DOI 10.1002/2211-5463.12519 ↗
- Paper Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mic… DOI 10.1093/carcin/bgx040 ↗
Hiroaki Taniguchi · 2 shared papers, 2017–2018 · strength 0.22
- Paper PRDM14 is overexpressed in chronic pancreatitis prior to pancreatic cancer. DOI 10.1002/2211-5463.12519 ↗
- Paper Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mic… DOI 10.1093/carcin/bgx040 ↗
Kazunori Kataoka · 1 shared paper, 2017 · strength 0.08
- Paper Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mic… DOI 10.1093/carcin/bgx040 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.